Thema
Letter
445
COVID-19 Vaccines
347
Journal Article
328
Comment
321
Editorial
196
Research Support, Non-U.S. Gov't
129
Antibodies, Viral
108
Interview
99
Antibodies, Neutralizing
98
BNT162 Vaccine
98
N38TVC63NU
94
Randomized Controlled Trial
68
Antiviral Agents
61
Multicenter Study
51
Research Support, N.I.H., Extramural
50
2019-nCoV Vaccine mRNA-1273
49
EPK39PL4R4
49
Spike Glycoprotein, Coronavirus
49
Viral Vaccines
47
Video-Audio Media
40
spike protein, SARS-CoV-2
39
B5S3K2V0G8
33
Case Reports
33
ChAdOx1 nCoV-19
33
3QKI37EEHE
30
415SHH325A
30
Adenosine Monophosphate
30
Alanine
30
OF5P57N2ZX
30
remdesivir
30
Antibodies, Monoclonal
28
Clinical Trial, Phase III
28
Antibodies, Monoclonal, Humanized
27
Comparative Study
26
RNA, Messenger
26
Vaccines
26
Vaccines, Synthetic
25
4QWG6N8QKH
23
Hydroxychloroquine
23
Immunoglobulin G
20
O3J8G9O825
20
Ritonavir
20
Ad26COVS1
17
JT2NS6183B
17
Anticoagulants
16
Clinical Trial, Phase II
16
Glucocorticoids
12
I031V2H011
12
tocilizumab
12
2494G1JF75
11
mehr ...